Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 16.505% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) Cc1cc(=O)oc2cc(OCC(=O)NC3CC(C)(C)NC(C)(C)C3)ccc12
(b) O=C(NCCN1C(=O)CSC1=O)c1ccccc1
(c) Cc1ccc(C(=O)c2sc3c(c2N)c(=O)[nH]c(=O)n3CCc2ccccc2)cc1
(d) CS(=O)(=O)N1CCC(C(=O)N2CCN(c3ccccc3)CC2)CC1
(e) CN(C)S(=O)(=O)c1cccc(C(=O)N2CCc3ccccc32)c1
Answer: b. O=C(NCCN1C(=O)CSC1=O)c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(NCCN1C(=O)CSC1=O)c1ccccc1
O=C(NCCN1C(=O)CSC1=O)c1ccccc1
N-[2-(2,4-dioxo-1,3-thiazolidin-3-yl)ethyl]benzamide